ACTRN12620000880943尚未招募1 期
Methylphenidate sustained release in methamphetamine use disorder – a pilot, open label, safety study
Christopher Gale0 个研究点目标入组 10 人开始时间: 2020年9月4日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •(1)able to provide written informed consent;
- •(2)aged 18-65 years on the day of consent;
- •(3)Body Mass Index 17-35 kg/m2 at screening;
- •(4)meet DSM-5 criteria for methamphetamine use disorder as diagnosed using the PRISM (http://www.columbia.edu/~dsh2/prism/);
- •(5)Have a urine drug screen on day one that does not contain opiates, benzodiazepines, cannabinoids or stimulants.
排除标准
- •1.History of psychotic episodes, or evidence current or past psychosis on the PRISM
- •2.evidence from medical history of current significant or unstable cardiac or other medical conditions;
- •3.history of epilepsy, head trauma, or central nervous system diseases;
- •4.female patients who are pregnant or lactating;
- •5.participants who, in the opinion of the investigator, do not understand the information and procedures of the study, or would not be compliant with them.
- •6.Q-Tc of over 450 ms on 12 lead ECG
- •7.Premorbid ST changes consistent with previous ischaemia in 12 lead ECG.
- •8.A drug screen on any day that has more than methyphenidate in it.
研究者
相似试验
进行中（未招募）
不适用
Clinical trial of sustained release methylphenidate for Attention-Deficit-Hyperactivity-Disorder (ADHD) in adult criminal offenders with amphetamine addictio54 male prison inmates (27 in each treatment condition) that meet the DSM-IV criteria for amphetamine addiction and for ADHD and who are servicing their prison sentence are recruited.EUCTR2006-002249-35-SEAddiction Center Stockholm54
已完成
不适用
Clinical trial of sustained release methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD) in adult criminal offenders with amphetamine addictioISRCTN77940178Addiction Centre Stockholm (Beroendecentrum Stockholm) (Sweden)54
已完成
2 期
efficacy of extended- release methylphenidate on theory of mind ability of 7-9year old children with attention-deficit hyperactivity disorderIRCT20190827044633N1Shahid Beheshti University of Medical Sciences30
进行中（未招募）
1 期
Methylphenidate modified release as treatment of MS-associated fatigue.EUCTR2012-003418-15-ATMedizinische Universität Wien96
进行中（未招募）
1 期
Effectiveness of Extended Release Methylphenidate in Reducing Cannabis Use in Young Cannabis-Dependent Patients with Attention Deficit Hyperactivity Disorder (ADHD)MedDRA version: 20.1Level: LLTClassification code 10007177Term: Cannabis dependenceSystem Organ Class: 100000004873EUCTR2017-000386-77-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)70